AU2006239177B8 — Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
Assigned to Shionogi and Co Ltd · Expires 2012-02-16 · 14y expired
What this patent protects
The present invention is to provide a novel compound (I), having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof. Compound (I) wherein Z is…
USPTO Abstract
The present invention is to provide a novel compound (I), having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof. Compound (I) wherein Z is NR; R is hydrogen or lower alkyl; X is a single bond, a hetero atom group selected from O, S, SO, SO and NH, or lower alkylene or lower alkenylene in which the hetero atom group may intervene; R is optionally substituted aryl; R is hydrogen, a halogen, hydroxy, optionally substituted lower alkyl etc; and R and Z part taken together forms a ring, to form a polycyclic compound, including e.g., a tricyclic or tetracyclic compound.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.